(L to R) Peter Streibl, cluster general manager, Southeast Asia & India, Takeda with Consul-General of Japan in Bengaluru Hiroshi Nawata, Takeda’s head of intercontinental markets Dr Mahender Nayak, Dr Reddy’s Laboratories CEO for global generics MV Ramana and Sandeep Khandelwal, CEO for Asia, Africa, Australia, CISUR & global generics India at Dr Reddy’s Laboratories at the announcement of the agreement between the two companies for the distribution of Takeda Pharmaceutical’s dengue vaccine Qdenga in India’s private market.
You Can Also Check: Gold Rate in Hyderabad | Silver Rate in Hyderabad | Bank Holidays in Hyderabad | Public Holidays in Hyderabad | Hyderabad AQI | Weather in Hyderabad | Petrol Price in Hyderabad | Diesel Price in Hyderabad | CNG Price in Hyderabad | LPG Price in Hyderabad Hyderabad: Dr Reddy’s Laboratories on Friday said it entered into an exclusive agreement with Takeda Pharmaceutical Company to promote and distribute the Japanese giant’s dengue vaccine, QDENGA, in India’s private paediatric and adult vaccination market.